MDXG vs. CRAI
MDXG (MiMedx Group, Inc.) and CRAI (CRA International, Inc.) are both stocks. MDXG operates in Medical Devices (Healthcare), while CRAI operates in Consulting Services (Industrials). Over the past 10 years, MDXG returned -6.98%/yr vs 20.77%/yr for CRAI. At a 0.14 correlation, their price movements are largely independent.
Performance
MDXG vs. CRAI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MDXG achieves a -45.79% return, which is significantly lower than CRAI's -29.60% return. Over the past 10 years, MDXG has underperformed CRAI with an annualized return of -6.98%, while CRAI has yielded a comparatively higher 20.77% annualized return.
MDXG
- 1D
- 0.00%
- 1M
- 1.38%
- YTD
- -45.79%
- 6M
- -47.87%
- 1Y
- -36.83%
- 3Y*
- -17.14%
- 5Y*
- -19.80%
- 10Y*
- -6.98%
CRAI
- 1D
- 1.14%
- 1M
- -5.00%
- YTD
- -29.60%
- 6M
- -33.22%
- 1Y
- -20.99%
- 3Y*
- 13.68%
- 5Y*
- 11.72%
- 10Y*
- 20.77%
MDXG vs. CRAI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MDXG MiMedx Group, Inc. | -45.79% | -29.63% | 9.69% | 215.47% | -53.97% | -33.48% | 19.79% | 323.46% | -85.80% | 42.33% |
CRAI CRA International, Inc. | -29.60% | 8.68% | 91.38% | -18.07% | 32.94% | 85.67% | -4.47% | 30.42% | -4.04% | 24.75% |
Correlation
The correlation between MDXG and CRAI is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.30 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Aug 22, 2007 | 0.14 |
The correlation between MDXG and CRAI shifts across timeframes, from 0.14 (all time) to 0.30 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
MDXG:
$544.80M
CRAI:
$924.16M
MDXG:
$0.21
CRAI:
$7.21
MDXG:
17.85
CRAI:
19.46
MDXG:
0.00
CRAI:
1.77
MDXG:
1.41
CRAI:
1.21
MDXG:
2.24
CRAI:
4.66
MDXG:
$389.42M
CRAI:
$770.71M
MDXG:
$315.59M
CRAI:
$156.66M
MDXG:
$53.81M
CRAI:
$95.16M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MDXG vs. CRAI — Risk / Return Rank
MDXG
CRAI
MDXG vs. CRAI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for MiMedx Group, Inc. (MDXG) and CRA International, Inc. (CRAI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MDXG | CRAI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.30 | ||
| Sortino ratioReturn per unit of downside risk | -0.61 | ||
| Omega ratioGain probability vs. loss probability | 0.86 | 0.93 | -0.07 |
| Calmar ratioReturn relative to maximum drawdown | -0.60 | -0.55 | -0.05 |
| Martin ratioReturn relative to average drawdown | -1.15 | -1.06 | -0.09 |
Loading charts...
Drawdowns
MDXG vs. CRAI - Drawdown Comparison
The maximum MDXG drawdown since its inception was -93.83%, which is greater than CRAI's maximum drawdown of -76.40%. Use the drawdown chart below to compare losses from any high point for MDXG and CRAI.
Loading charts...
Drawdown Indicators
| MDXG | CRAI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.83% | -76.40% | -17.43% |
Max Drawdown (1Y)Largest decline over 1 year | -61.24% | -38.12% | -23.12% |
Max Drawdown (3Y)Largest decline over 3 years | -68.36% | -38.12% | -30.24% |
Max Drawdown (5Y)Largest decline over 5 years | -83.39% | -38.12% | -45.27% |
Max Drawdown (10Y)Largest decline over 10 years | -93.60% | -60.74% | -32.86% |
Current DrawdownCurrent decline from peak | -79.57% | -36.74% | -42.83% |
Average DrawdownAverage peak-to-trough decline | -53.56% | -33.47% | -20.09% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 32.14% | 19.91% | +12.23% |
Volatility
MDXG vs. CRAI - Volatility Comparison
The current volatility for MiMedx Group, Inc. (MDXG) is 9.64%, while CRA International, Inc. (CRAI) has a volatility of 12.32%. This indicates that MDXG experiences smaller price fluctuations and is considered to be less risky than CRAI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MDXG | CRAI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.64% | 12.32% | -2.68% |
Volatility (6M)Calculated over the trailing 6-month period | 30.57% | 31.10% | -0.53% |
Volatility (1Y)Calculated over the trailing 1-year period | 42.94% | 37.66% | +5.28% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 61.94% | 34.80% | +27.14% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 73.95% | 38.77% | +35.18% |
Dividends
MDXG vs. CRAI - Dividend Comparison
MDXG has not paid dividends to shareholders, while CRAI's dividend yield for the trailing twelve months is around 1.57%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
CRAI CRA International, Inc. | 1.57% | 1.26% | 0.93% | 1.52% | 1.05% | 1.17% | 1.87% | 1.52% | 1.67% | 1.31% | 0.38% |
MDXG MiMedx Group, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
MDXG vs. CRAI - Financials Comparison
This section allows you to compare key financial metrics between MiMedx Group, Inc. and CRA International, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MDXG vs. CRAI - Profitability Comparison
MDXG - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, MiMedx Group, Inc. reported a gross profit of 41.62M and revenue of 58.99M. Therefore, the gross margin over that period was 70.6%.
CRAI - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CRA International, Inc. reported a gross profit of 0.00 and revenue of 200.98M. Therefore, the gross margin over that period was 0.0%.
MDXG - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, MiMedx Group, Inc. reported an operating income of -16.05M and revenue of 58.99M, resulting in an operating margin of -27.2%.
CRAI - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CRA International, Inc. reported an operating income of 18.03M and revenue of 200.98M, resulting in an operating margin of 9.0%.
MDXG - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, MiMedx Group, Inc. reported a net income of -10.86M and revenue of 58.99M, resulting in a net margin of -18.4%.
CRAI - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CRA International, Inc. reported a net income of 11.13M and revenue of 200.98M, resulting in a net margin of 5.5%.
Frequently Asked Questions
MDXG and CRAI have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRAI has higher volatility (12.32%) compared to MDXG (9.64%). In terms of maximum drawdown, MDXG dropped -93.83% vs CRAI's -76.40%.
CRAI currently has the higher Sharpe Ratio (-0.56 vs -0.86), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MDXG and CRAI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer